2021 - 2024 Metabolomics of biomolecules in serum from individuals with at-risk mental state and first-episode psychosis: discovery of reliable marker to develop psychosis
Papers (15):
*Shinichiro Ochi, Fumitoshi Kodaka, Naomi Hasegawa, Jun-Ichi Iga, Hiroko Kashiwagi, Hiroshi Komatsu, Hiromi Tagata, Takashi Tsuboi, Shusuke Numata, Hitoshi Iida, et al. ASSOCIATIONS OF CLOZAPINE AVAILABLE INSTITUTION AND THE DIAGNOSIS OF SUBGROUPS ABOUT TREATMENT-RESISTANT SCHIZOPHRENIA OR NOT WITH A HIGHER RATE OF ANTIPSYCHOTIC MONOTHERAPY AND LOWER OTHER CONCOMITANT PSYCHOTROPICS IN OVERALL SCHIZOPHRENIA TREATMENT: A REAL-WORLD NATIONWIDE STUDY. International Journal of Neuropsychopharmacology. 2025. 28. Supplement_1. i163-i164
Junichi Saito, Naoyuki Katagiri, Hiromi Tagata, Yu Arai, Kouhei Kamiya, Masaaki Hori, Masafumi Mizuno, Takahiro Nemoto. Associations between Verbal Fluency and Asymmetry of White Matter Integrity in the Superior Longitudinal Fasciculus in At-Risk Mental States for Psychosis. Journal of personalized medicine. 2024. 14. 3
Shinichiro Ochi, Hiromi Tagata, Naomi Hasegawa, Norio Yasui-Furukori, Jun-Ichi Iga, Hiroko Kashiwagi, Fumitoshi Kodaka, Hiroshi Komatsu, Takashi Tsuboi, Akira Tokutani, et al. Clozapine Treatment Is Associated With Higher Prescription Rate of Antipsychotic Monotherapy and Lower Prescription Rate of Other Concomitant Psychotropics: A Real-World Nationwide Study. The international journal of neuropsychopharmacology. 2022. 25. 10. 818-826